scispace - formally typeset
Search or ask a question

Answers from top 10 papers

More filters
Papers (10)Insight
These data justify progression of this next generation AMA1 vaccine towards human trials. Malaria: Inhibiting parasite invasion of red blood cellsA vaccine targeting a protein complex that allows malaria-causing parasite to enter red blood cells has been produced.
Journal ArticleDOI
Georgetta Cannon, Drew Weissman 
105 Citations
RNA, on the other hand, is readily taken up and expressed by DC, making it an alternative vaccine candidate.
Although much progress is required for the development of a vaccine that provides sustainable protective immunity against malaria, a strategy using DNA vaccine technology as a core component of such a vaccine is promising.
Open accessJournal ArticleDOI
Amed Ouattara, Matthew B. Laurens 
68 Citations
Currently, there is no licensed vaccine against malaria, but an efficacious vaccine would represent an important public health tool for successful malaria elimination.
DNA-based vaccines are a new technology that may hold hope for an effective malaria vaccine.
Hybrid molecules of this type may be the basis of a malaria vaccine.
Our findings demonstrate that a safe and effective, genetically attenuated whole-organism malaria vaccine is possible.
Two human models of immunity to malaria, however, suggest that the development of an effective vaccine is within reach.
Journal ArticleDOI
Stephen Todryk, Adrian V. S. Hill 
58 Citations
With over 1 million deaths annually attributed to malaria, an effective vaccine is an urgently needed intervention.
We therefore developed a semi-synthetic whole parasite malaria vaccine that is easily manufactured and stored.